FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1994401508> ?p ?o ?g. }

• W1994401508 endingPage "2261" @default.
• W1994401508 startingPage "2256" @default.
• W1994401508 abstract "ABSTRACT The aims of this study were to describe emtricitabine concentration-time courses in a large population of HIV-1-infected adults, to evaluate the influence of renal function on emtricitabine disposition, and to assess current dosing adjustment recommendations. Emtricitabine blood plasma concentrations were determined from samples collected from 161 adult patients during therapeutic drug monitoring and measured by liquid chromatography coupled to tandem mass spectrometry. The data were analyzed by a population approach. Emtricitabine pharmacokinetics was best described by a two-compartment model in which the absorption and distribution rate constants were assumed to be equal. Typical population parameter estimates (interindividual variability) were apparent elimination and intercompartmental clearances of 15.1 liters/h (17.4%) and 5.75 liters/h, respectively, and apparent central and peripheral volumes of distribution of 42.3 liters and 55.4 liters, respectively. The apparent elimination clearance was significantly related to creatinine clearance (CL CR ), reflecting renal function. For 200 mg once a day (QD), the median area under the concentration-time curve over 24 h (AUC 0-24 ) was 12.5 mg · h/liter for patients with normal renal function (CL CR , >80 ml/min), 14.7 mg · h/liter for patients with mild renal impairment (CL CR , 79 to 50 ml/min), and 17.9 mg · h/liter for patients with moderate renal impairment (CL CR , 49 to 30 ml/min). Simulations of the recommended dosing schemes for the oral solid form of emtricitabine (i.e., 200 mg per 48 h according to renal function) led to lower emtricitabine exposures for patients with moderate renal impairment (median AUC 0-48 , 17.2 mg · h/liter) than for patients with normal renal function (median AUC 0-48 , 25.6 mg · h/liter). Administering 18 ml of emtricitabine oral solution (10 mg/ml) QD to patients with moderate renal impairment should yield emtricitabine exposures similar to those in patients with normal renal function." @default.
• W1994401508 created "2016-06-24" @default.
• W1994401508 creator A5004949197 @default.
• W1994401508 creator A5005683935 @default.
• W1994401508 creator A5014824428 @default.
• W1994401508 creator A5016638923 @default.
• W1994401508 creator A5029770079 @default.
• W1994401508 creator A5036305862 @default.
• W1994401508 creator A5036481508 @default.
• W1994401508 creator A5037696502 @default.
• W1994401508 creator A5075190555 @default.
• W1994401508 creator A5089598609 @default.
• W1994401508 date "2014-04-01" @default.
• W1994401508 modified "2023-10-18" @default.
• W1994401508 title "Population Pharmacokinetics of Emtricitabine in HIV-1-Infected Adult Patients" @default.
• W1994401508 cites W105671925 @default.
• W1994401508 cites W1550111394 @default.
• W1994401508 cites W1999521622 @default.
• W1994401508 cites W2006812669 @default.
• W1994401508 cites W2014393639 @default.
• W1994401508 cites W2015099468 @default.
• W1994401508 cites W2029352665 @default.
• W1994401508 cites W2040767617 @default.
• W1994401508 cites W2042553471 @default.
• W1994401508 cites W2094477939 @default.
• W1994401508 cites W2116382218 @default.
• W1994401508 cites W2134561708 @default.
• W1994401508 cites W2142706308 @default.
• W1994401508 cites W2159601567 @default.
• W1994401508 cites W2167655842 @default.
• W1994401508 cites W2171909957 @default.
• W1994401508 cites W4229880569 @default.
• W1994401508 cites W4240755780 @default.
• W1994401508 doi "https://doi.org/10.1128/aac.02058-13" @default.
• W1994401508 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4023733" @default.
• W1994401508 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24492366" @default.
• W1994401508 hasPublicationYear "2014" @default.
• W1994401508 type Work @default.
• W1994401508 sameAs 1994401508 @default.
• W1994401508 citedByCount "38" @default.
• W1994401508 countsByYear W19944015082014 @default.
• W1994401508 countsByYear W19944015082015 @default.
• W1994401508 countsByYear W19944015082016 @default.
• W1994401508 countsByYear W19944015082017 @default.
• W1994401508 countsByYear W19944015082018 @default.
• W1994401508 countsByYear W19944015082019 @default.
• W1994401508 countsByYear W19944015082020 @default.
• W1994401508 countsByYear W19944015082021 @default.
• W1994401508 countsByYear W19944015082022 @default.
• W1994401508 countsByYear W19944015082023 @default.
• W1994401508 crossrefType "journal-article" @default.
• W1994401508 hasAuthorship W1994401508A5004949197 @default.
• W1994401508 hasAuthorship W1994401508A5005683935 @default.
• W1994401508 hasAuthorship W1994401508A5014824428 @default.
• W1994401508 hasAuthorship W1994401508A5016638923 @default.
• W1994401508 hasAuthorship W1994401508A5029770079 @default.
• W1994401508 hasAuthorship W1994401508A5036305862 @default.
• W1994401508 hasAuthorship W1994401508A5036481508 @default.
• W1994401508 hasAuthorship W1994401508A5037696502 @default.
• W1994401508 hasAuthorship W1994401508A5075190555 @default.
• W1994401508 hasAuthorship W1994401508A5089598609 @default.
• W1994401508 hasBestOaLocation W19944015081 @default.
• W1994401508 hasConcept C112705442 @default.
• W1994401508 hasConcept C126322002 @default.
• W1994401508 hasConcept C126894567 @default.
• W1994401508 hasConcept C139254425 @default.
• W1994401508 hasConcept C142462285 @default.
• W1994401508 hasConcept C159641895 @default.
• W1994401508 hasConcept C176674119 @default.
• W1994401508 hasConcept C185592680 @default.
• W1994401508 hasConcept C192670549 @default.
• W1994401508 hasConcept C203014093 @default.
• W1994401508 hasConcept C2777288759 @default.
• W1994401508 hasConcept C2779778239 @default.
• W1994401508 hasConcept C2908647359 @default.
• W1994401508 hasConcept C2993143319 @default.
• W1994401508 hasConcept C3013748606 @default.
• W1994401508 hasConcept C71924100 @default.
• W1994401508 hasConcept C98274493 @default.
• W1994401508 hasConcept C99454951 @default.
• W1994401508 hasConceptScore W1994401508C112705442 @default.
• W1994401508 hasConceptScore W1994401508C126322002 @default.
• W1994401508 hasConceptScore W1994401508C126894567 @default.
• W1994401508 hasConceptScore W1994401508C139254425 @default.
• W1994401508 hasConceptScore W1994401508C142462285 @default.
• W1994401508 hasConceptScore W1994401508C159641895 @default.
• W1994401508 hasConceptScore W1994401508C176674119 @default.
• W1994401508 hasConceptScore W1994401508C185592680 @default.
• W1994401508 hasConceptScore W1994401508C192670549 @default.
• W1994401508 hasConceptScore W1994401508C203014093 @default.
• W1994401508 hasConceptScore W1994401508C2777288759 @default.
• W1994401508 hasConceptScore W1994401508C2779778239 @default.
• W1994401508 hasConceptScore W1994401508C2908647359 @default.
• W1994401508 hasConceptScore W1994401508C2993143319 @default.
• W1994401508 hasConceptScore W1994401508C3013748606 @default.
• W1994401508 hasConceptScore W1994401508C71924100 @default.
• W1994401508 hasConceptScore W1994401508C98274493 @default.
• W1994401508 hasConceptScore W1994401508C99454951 @default.

• next